16th Biosimilar Medicines Conference

14th Legal Affairs Conference

17th Regulatory and Scientific Affairs Conference

11th Medicines for Europe Pharmacovigilance Conference

IGBA 2017 achievements – Adrian van den Hoven

How come that biosimilar medicines are still heavily debated today?

What is needed to familiarize oncologists with biosimilar medicines?

What is the role of clinical trials in biosimilar development?

What are the key messages of the ESMO 2017 symposium?

My Voice Matters! Integrating Patient’s Preferences in the Healthcare Agenda